Through the collaborative efforts of the TENET COST Action network, a comprehensive review article on Achilles tendinopathy has been recently published in Nature Reviews Disease Primers. This journal is one of the top ten most influential scientific journals worldwide , underlining its importance and international visibility.
The publication offers a complete review on rehabilitation strategies, the development of advanced therapies, and the integration of precision medicine — all aimed at improving treatment outcomes. This in-depth review covers topics ranging from the epidemiology and pathophysiology of Achilles tendinopathy to its diagnosis and the most promising treatments currently being studied.
This work is the result of a global, multidisciplinary collaboration involving researchers from Europe, Canada, the United States, the United Kingdom and Brazil. The study was led by Professors Britt Wildemann from the University Hospital of Jena in Germany, and Andreas Traweger from the Paracelsus Medical University in Salzburg, Austria, both key members of TENET.
The Achilles heel, a weakness still prevalent in modern life
In Greek mythology, Achilles was said to be invincible, except for his heel. Today, that same tendon remains a vulnerable spot for many, particularly among active individuals. Achilles tendinopathy is a common injury that affects the tendon that connects the calf muscles (gastrocnemius and soleus) to the heel bone (calcaneus), leading to pain, difficulty performing daily tasks, and, in many cases, a reduced quality of life.
Achilles tendinopathy affects approximately 2 in every 1,000 individuals annually, with significantly higher incidence observed in athletic populations, highlighting its relevance both in clinical practice and in sports medicine. Contributing factors include ageing, genetic predisposition, overtraining, certain metabolic diseases, and the use of certain medications.
Treatment of Achilles tendinopathy remains a clinical challenge. Experts advocate for pain-guided rehabilitation using progressive loading exercises, considering surgery only as a last resort. Current research is focused on developing new therapies that not only alleviate symptoms but also regenerate tendon tissue, tailored to each patient through precision medicine.
This publication underscores the impact of international collaboration in advancing medical science and sheds new light on one of the most persistent injuries in both sports and everyday life.
